These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19302443)

  • 1. Antineoplastic effects of Magnoliae officinalis in tumours other than hepatomas.
    Kapoor S
    Liver Int; 2009 Jul; 29(6):951-2; author reply 952-3. PubMed ID: 19302443
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytotoxic lignans from the stem bark of Magnolia officinalis.
    Youn UJ; Chen QC; Jin WY; Lee IS; Kim HJ; Lee JP; Chang MJ; Min BS; Bae KH
    J Nat Prod; 2007 Oct; 70(10):1687-9. PubMed ID: 17918910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of P-glycoprotein expression by honokiol, magnolol and 4-O-methylhonokiol, the bioactive components of Magnolia officinalis.
    Han HK; Van Anh LT
    Anticancer Res; 2012 Oct; 32(10):4445-52. PubMed ID: 23060571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of the active compounds of M. officinalis on cariogenic bacteria].
    Feng J; Li JY; Zhou XD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jun; 38(3):456-8. PubMed ID: 17593830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effect of ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on memory impairment and neuronal toxicity induced by beta-amyloid.
    Lee JW; Lee YK; Lee BJ; Nam SY; Lee SI; Kim YH; Kim KH; Oh KW; Hong JT
    Pharmacol Biochem Behav; 2010 Mar; 95(1):31-40. PubMed ID: 20004682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study on genuineness of traditional Chinese medicine cortex Magnoliae officinalis].
    Si J
    Zhong Yao Cai; 2000 Jul; 23(7):373-5. PubMed ID: 12575165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphenyl-type neolignans from stem bark of Magnolia officinalis with potential anti-tumor activity.
    Ni HF; Cai X; Qiu X; Liu L; Ma X; Wan L; Ye H; Chen L
    Fitoterapia; 2020 Nov; 147():104769. PubMed ID: 33152462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactive polar compounds from stem bark of Magnolia officinalis.
    Yu SX; Yan RY; Liang RX; Wang W; Yang B
    Fitoterapia; 2012 Mar; 83(2):356-61. PubMed ID: 22155594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on HPLC chromatogram of phenolic constituents of Cortex Magnoliae Officinalis].
    Huang WH; Guo BL; Si JP
    Zhongguo Zhong Yao Za Zhi; 2005 Jul; 30(13):968-71. PubMed ID: 16161419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential proteomic analysis of HeLa cells treated with Honokiol using a quantitative proteomic strategy.
    Ling B; Liang SF; Xu YH; Zhao XY; Tang MH; Liu XY; Zhao X; Huang CH; Chen LJ; Wei YQ
    Amino Acids; 2008 Jun; 35(1):115-22. PubMed ID: 18157584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity and cytotoxic effects of Magnolia dealbata and its active compounds.
    Jacobo-Salcedo Mdel R; Gonzalez-Espindola LA; Alonso-Castro AJ; Gonzalez-Martinez Mdel R; Domínguez F; Garcia-Carranca A
    Nat Prod Commun; 2011 Aug; 6(8):1121-4. PubMed ID: 21922914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new dimeric neolignan from Magnolia grandiflora L. seeds.
    Li HM; Zhao SR; Huo Q; Ma T; Liu H; Lee JK; Hong YS; Wu CZ
    Arch Pharm Res; 2015 Jun; 38(6):1066-71. PubMed ID: 25193624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The relationship between the quality and the leaf shape of Magnolia officinalis produced in Hubei enshi].
    Yang HB; Shi L; Yu JJ; Li MM
    Zhong Yao Cai; 2012 Jul; 35(7):1036-9. PubMed ID: 23252263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnolia dealbata seeds extract exert cytotoxic and chemopreventive effects on MDA-MB231 breast cancer cells.
    Alonso-Castro AJ; Domínguez F; García-Regalado A; González-Sánchez I; Cerbón MA; García-Carrancá A
    Pharm Biol; 2014 May; 52(5):621-7. PubMed ID: 24400594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New obovatol trimeric neolignans with NO inhibitory activity from the leaves of Magnolia officinalis var. biloba.
    Vu VT; Liu XQ; Nguyen MT; Lin YL; Kong LY; Luo JG
    Bioorg Chem; 2020 Mar; 96():103586. PubMed ID: 31982819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities.
    Kumar A; Kumar Singh U; Chaudhary A
    Future Med Chem; 2013 May; 5(7):809-29. PubMed ID: 23651094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the relationship between provenance, leaf type and quality in Magnolia officinalis].
    Si J; Pan X; Tong Z; Zeng Y
    Zhong Yao Cai; 1998 Nov; 21(11):541-3. PubMed ID: 12569815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advance in latest studies on pharmacological effects of magnolol].
    Zhang Y; Tang F
    Zhongguo Zhong Yao Za Zhi; 2012 Dec; 37(23):3526-30. PubMed ID: 23477132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening active anti-breast cancer compounds from Cortex Magnolia officinalis by 2D LC-MS.
    Hou X; Yuan X; Zhang B; Wang S; Chen Q
    J Sep Sci; 2013 Feb; 36(4):706-12. PubMed ID: 23401389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors.
    Song JM; Anandharaj A; Upadhyaya P; Kirtane AR; Kim JH; Hong KH; Panyam J; Kassie F
    Oncotarget; 2016 Sep; 7(36):57752-57769. PubMed ID: 27458163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.